Ivana Magovcevic-Liebisch
CIK: 0001279281
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Acrivon Therapeutics noted among health‑care stocks moving in after‑market. Acrivon Therapeutics (ACRV) was included in a Benzinga roundup of twelve health‑care stocks that showed price movement during Wednesday’s after‑market session. The mention signals recent trading activity after regular hours. The stock is currently near its 52‑week low and its RSI is below 40, suggesting limited momentum.
Transaction History
| QTRX | ▲ Buy | Option Exercise | 4,224 | — | 10/2/2026 | View on chart |
| ACRV | ▲ Buy | Grant | 9,366 | $0 | 5/18/2026 | View on chart |
| QTRX | ▲ Buy | Grant | 23,372 | $0 | 1/2/2026 | View on chart |
| QTRX | ▲ Buy | Grant | 7,435 | $0 | 1/2/2025 | View on chart |
| QTRX | ▲ Buy | Grant | 12,800 | $0 | 10/2/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Quanterix Highlights Spatial Biology Innovation at ESSB 2026
Quanterix announced it met its spatial biology content innovation commitments during the ESSB 2026 event. The company showcased new tools and data sets that support advanced spatial analysis. This demonstrates progress in its product roadmap and may strengthen its position in the spatial biology market.
Quanterix Highlights Spatial Biology Innovation at ESSB 2026. Quanterix announced it met its spatial biology content innovation commitments during the ESSB 2026 event. The company showcased new tools and data sets that support advanced spatial analysis. This demonstrates progress in its product roadmap and may strengthen its position in the spatial biology market.